A Comparative Study Between Combination of Propofol and Dexmedetomidine Versus Propofol Alone in Anesthesia for Rigid Bronchoscopy by Using the Patient State Index Monitor
NCT07409935 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2026-02-13
Summary
Standard ASA fasting guidelines will be followed. IV 20 gauge cannula will be inserted and dedicated to the infusion drugs. Standard ASA monitors will be attached, and baseline heart rate (HR), mean arterial blood pressure (MAP), and oxygen saturation (SpO2) will be recorded. The SedLine Brain Function Monitor's electrode (Masimo O3™, Masimo corporation, Irvine, California, USA) will be positioned on the patient's forehead.
Fifty Patients will be involved in this study and randomized into two groups: 25 patients as propofol/dexmedetomidine (PD) group and another 25 patients as propofol/saline (PS) group. The PD group will receive dexmedetomidine 0.5 µ/kg bolus over 10 min before induction of anesthesia followed by a continuous infusion of (0.5 µ/kg/h) throughout the procedure . PS group will receive normal saline infusion over 10 min before induction of anesthesia and then throughout the procedure with an infusion rate adjusted to match dexmedetomidine infusion in PD group.
Anesthesia protocol, Induction of anesthesia in all patients will be done with 1% IV propofol (2 mg/kg), and IV fentanyl (2 µ/kg), IV atracurium (0.5mg/kg). Ventilation will be achieved by face mask until introduction of RB. When RB is introduced, rapid manual jet ventilation by venturi technique, In case of hypoxemia (SPO2 \< 90%), bronchoscope will be used as an endotracheal tube by occluding the main port of bronchoscope and patient will be ventilated by providing intermittent positive pressure ventilation. In case of persistent hypoxemia despite adequate jet ventilation, RB will be withdrawn followed by endotracheal intubation and mechanical ventilation. Anesthesia is maintained by propofol infusion started in both groups in 4 mg/kg/h. Rate of propofol infusion will be adjusted to maintain PSI between 25-50 in order to ensure adequate depth of anesthesia. After insertion of RB above the level of carina and before proceeding to the desired bronchus, 2% lidocaine 2-3 ml will be instilled in the targeted bronchus through suction port. Hydrocortisone 100 mg will be given to minimize laryngeal edema.
At the end of the procedure, RB will be removed and replaced with a regular endotracheal tube to secure the airway, infusions will be stopped and muscle relaxation will be reversed by using neostigmine and atropine when clinically observed that it is proper timing. After end of procedure, Modified Observer's Assessment of Alertness/Sedation scale (MOAAS) will be recorded every 10 min after bronchoscopy removal. The following descriptions of MOAAS scores will be used: 0 does not respond to pain; 1 does not respond to mild prodding or shaking; 2 responds after mild prodding or shaking; 3 responds after calling loudly or repeatedly; 4 responds slowly to voice with normal tone; 5 responds readily to voice with normal tone. Patients will be transferred to the post anesthesia care unit (PACU) when MOAAS scale in between 4 and 5. They will be observed for 2-3 h in PACU for complications and hemodynamic changes, The patient will be asked if he remember anything between going to sleep and waking by using modified Brice questionnaire: 1. What was the last thing you remembered before going to sleep? 2. What was the first thing you remembered on waking? 3. Do you remember anything between going to sleep and waking? 4. While you were sleeping during the operation, did you dream?.
Conditions
- Patients Undergoing Rigid Bronchoscopy
Interventions
- DRUG
-
Propofol saline
25 Patients were assigned propofol/saline (PS) group. The PS group received normal saline infusion over 10 min before induction of anesthesia and then throughout the procedure with an infusion rate adjusted to match dexmedetomidine infusion in propofol/dexmedetomidine (PD) group. Induction of anesthesia in all patients was done with 1% IV propofol (2 mg/kg), and IV fentanyl (2 µ/kg), IV atracurium (0.5mg/kg). Ventilation was achieved by face mask . When RB was introduced, rapid manual jet ventilation by venturi technique. Anesthesia was maintained by propofol infusion started in both groups in 4 mg/kg/h. Rate of propofol infusion was adjusted to maintain PSI between 25-50 in order to ensure adequate depth of anesthesia. At the end of the procedure, RB was removed and replaced with a regular endotracheal tube to secure the airway, infusions stopped and muscle relaxation reversed by using neostigmine and atropine when clinically observed that it was proper timing.
- DRUG
-
Propofol Dexmedetomidine
25 Patients were involved as propofol/dexmedetomidine (PD) group. The PD group received dexmedetomidine 0.5 µ/kg bolus over 10 min before induction of anesthesia followed by a continuous infusion of (0.5 µ/kg/h) throughout the procedure. Induction of anesthesia in all patients was done with 1% IV propofol (2 mg/kg), and IV fentanyl (2 µ/kg), IV atracurium (0.5mg/kg). Ventilation was achieved by face mask . When RB was introduced, rapid manual jet ventilation by venturi technique. Anesthesia was maintained by propofol infusion started in both groups in 4 mg/kg/h. Rate of propofol infusion was adjusted to maintain PSI between 25-50 in order to ensure adequate depth of anesthesia. At the end of the procedure, RB was removed and replaced with a regular endotracheal tube to secure the airway, infusions stopped and muscle relaxation was reversed by using neostigmine and atropine when clinically observed that it was proper timing.
Sponsors & Collaborators
-
Cairo University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-04-01
- Primary Completion
- 2025-04-01
- Completion
- 2025-10-01
Countries
- Egypt
Study Locations
More Related Trials
-
Comparison of Different Propofol Formulations
NCT01041872 ·Status: COMPLETED ·Phase: PHASE4
-
Propofol Versus Midazolam+Alfentanil for Sedation During Bronchoscopy: Comparison by Cutaneous Carbon Dioxide Tension
NCT01289327 ·Status: COMPLETED ·Phase: NA
-
Application of Low-dose Muscle Relaxants in Bronchoscopic Interventional Procedures
NCT07035301 ·Status: COMPLETED ·Phase: NA
-
ED90 of Fospropofol Disodium in Induction and Maintenance of Anesthesia
NCT06344325 ·Status: COMPLETED ·Phase: PHASE4
-
Non-anesthesiologist-administered Propofol During the Flexible Bronchoscopy
NCT02820051 ·Status: COMPLETED ·Phase: NA
-
A Study Evaluating the Safety and Pharmacokinetics/Pharmacodynamics of HSK3486
NCT03745625 ·Status: COMPLETED ·Phase: PHASE1
-
Propofolsleep - A Study on Cardiopulmonary and Pharyngeal Reactions While Drug Induced Sleep Endoscopy (DISE)
NCT03224936 ·Status: COMPLETED
-
Comparison of Propofol/Alfentanil With Propofol/Ketamine
NCT02000206 ·Status: UNKNOWN ·Phase: NA
-
Effect of the Duration of Pre-oxygenation on Apnea Tolerance in Obese Patients During the Induction of General Anesthesia
NCT04699435 ·Status: UNKNOWN ·Phase: NA
-
Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy
NCT02246023 ·Status: COMPLETED ·Phase: PHASE4
-
Controlled Propofol Administration
NCT01019746 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of BIS-guided Propofol Induction on Hemodynamic Response in Patients With Cardiac Risk.
NCT04729465 ·Status: UNKNOWN ·Phase: NA
-
Bronchoscopy and Bispectral Index (BIS) - Guided Sedation
NCT00839371 ·Status: COMPLETED ·Phase: PHASE4
-
Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl-sedation for Flexible Bronchoscopy: A Randomized, Single Blind, Controlled Study of Satisfaction and Safety.
NCT02226328 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of HSK3486 Compared to Propofol for Adults Undergoing Elective Surgery With General Anesthesia
NCT05478174 ·Status: COMPLETED ·Phase: PHASE3
-
Regimen of Alfentanil in Propofol Sedative Fibro-bronchoscopy
NCT01470170 ·Status: COMPLETED ·Phase: PHASE4
-
The Application and Validation of Triple Drug Response Surface Models on Density Spectral Array in Clinical Anesthesia
NCT05525351 ·Status: UNKNOWN
-
Bispectral Index Monitoring In Pediatric Cataract Surgery: A Comparative Study Using Propofol-Midazolam Versus Sevoflurane Anesthesia
NCT05262205 ·Status: COMPLETED ·Phase: NA
-
Minimal Effective Concentration of Lidocaine in Propofol Lidocaine Mixture for Relief of Pain on Propofol Injection
NCT05165303 ·Status: UNKNOWN ·Phase: PHASE4
-
Hemodynamic Effects of a High Dose Versus Low Dose Propofol During Induction of Anesthesia.
NCT06651749 ·Status: RECRUITING ·Phase: NA
-
Optimal Lidocaine Propofol Mixture for Painless Induction of Anesthesia
NCT05898061 ·Status: UNKNOWN
-
Target-Controlled Infusion of Propofol for Flexible Bronchoscopy Sedation
NCT01101477 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of Fospropofol Disodium Versus Propofol for Sedation in Mechanically Ventilated ICU Patients
NCT05491278 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Fospropofol Disodium Versus Propofol for Deep Sedation in Critically Ill Patients
NCT05870514 ·Status: UNKNOWN ·Phase: PHASE2
-
Propofol Versus Sevoflurane Anesthesia in Pediatric Strabismus Surgery: Feasibility of BIS Monitoring
NCT04485117 ·Status: COMPLETED ·Phase: NA